Agoracom: Small Cap Investment - BIOASIS TECHNOLOGIES INC - Armagen reports early positive Phase II data for AGT-181

Welcome to the Bioasis Technologies Hub On AGORACOM

Reply New Message

Back To Forum List View

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Armagen reports early positive Phase II data for AGT-181

posted on Feb 17, 2017 11:49AM

Trial shows ArmaGen biologic improves cognition in Hurler syndrome patients

I can see this being interpreted both ways. Positive: Proof of concept that trojan horse technologies yield positive clinical data for LSD programs in humans. Negative: BiOasis is not at the same clinical stage as Armagen. I'm curious for others thoughts on this.

BearDownAZ

Reply New Message

Back To Forum List View

Please to post a reply